Br Med J (Clin Res Ed) 1984;288:545-547 (18 February), doi:10.1136/bmj.288.6416.545
Tardive dyskinesia associated with metoclopramide.
B E Wiholm,
O Mortimer,
G Boethius,
J E Häggström
Eleven cases of tardive dyskinesia associated with metoclopramide
have been reported to the Swedish Adverse Drug Reactions Advisory
Committee from 1977 to 1981, 10 of which developed during the
past three years. All patients were women, with a mean age of
76 years. Median duration of treatment before the onset of symptoms
was 14 months. Calculated from total drug sales and prescription
statistics the incidence of tardive dyskinesia during treatment
with metoclopramide was estimated to be one in 2000-2800 treatment
years. Extrapolation of data on long term treatment (more than
six months) of patients aged 70 years or more, from a survey
based on individual prescriptions yielded an incidence of more
than one in a 1000 patients. Long term treatment with metoclopramide
is accompanied by a substantial risk of developing tardive dyskinesia
especially among elderly people.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
This article has been cited by other articles:
-
Ganzini, L., Casey, D. E., Hoffman, W. F., McCall, A. L.
(1993). The Prevalence of Metoclopramide-Induced Tardive Dyskinesia and Acute Extrapyramidal Movement Disorders. Arch Intern Med
153: 1469-1475
[Abstract]
-
Sewell, D. D., Jeste, D. V.
(1992). Metoclopramide-Associated Tardive Dyskinesia: An Analysis of 67 Cases. Arch Fam Med
1: 271-278
[Abstract]
-
Ganzini, L., Heintz, R. T., Hoffman, W. F., Casey, D. E.
(1991). The Prevalence of Tardive Dyskinesia in Neuroleptic-Treated Diabetics: A Controlled Study. Arch Gen Psychiatry
48: 259-263
[Abstract]
-
Miller, L. G., Jankovic, J.
(1989). Metoclopramide-Induced Movement Disorders: Clinical Findings With a Review of the Literature. Arch Intern Med
149: 2486-2492
[Abstract]